Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBKIR.L Regulatory News (BKIR)

  • There is currently no data for BKIR

Potential Additional Tier 1 Transaction

8 Jun 2015 10:45

RNS Number : 4967P
Bank of Ireland(Governor&Co)
08 June 2015
 



The Governor and Company of the Bank of Ireland (the ''Group'')

Potential Additional Tier 1 Transaction

8 June 2015

_______________________________________________________________________________

 

The Governor and Company of the Bank of Ireland ("the Bank") has mandated Deutsche Bank and UBS Investment Bank as Joint Structuring Advisors and Joint Bookrunners and Bank of America Merrill Lynch, Credit Suisse, Davy and Morgan Stanley as Joint Bookrunners for the issue of EUR-denominated RegS CRR compliant 5.125% CET1 trigger Fixed Rate Reset Additional Tier 1 Perpetual Contingent Temporary Write-Down Securities (the "Securities"). The issue and sale of the Securities remains subject to market conditions and will follow a UK and European roadshow which will commence on 9 June 2015. FCA/ICMA stabilisation.

Ends

 

For further information please contact:

 

Bank of Ireland

Andrew Keating Group Chief Financial Officer +353 (0)766 23 5141

Brian Kealy Head of Capital Management +353 (0)766 23 4719

Colin Reddy Deputy Head of Capital Management +353 (0)766 23 4722

Mark Spain Director of Group Investor Relations +353 (0)766 23 4850

Pat Farrell Head of Group Communications +353 (0)766 23 4770

  

Forward Looking Statement

This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934 and Section 27A of the US Securities Act of 1933 with respect to certain of the Bank of Ireland Group's (the 'Group') plans and its current goals and expectations relating to its future financial condition and performance, the markets in which it operates, and its future capital requirements. These forward-looking statements often can be identified by the fact that they do not relate only to historical or current facts. Generally, but not always, words such as 'may,' 'could,' 'should,' 'will,' 'expect,' 'intend,' 'estimate,' 'anticipate,' 'assume,' 'believe,' 'plan,' 'seek,' 'continue,' 'target,' 'goal', 'would,' or their negative variations or similar expressions identify forward-looking statements, but their absence does not mean that a statement is not forward looking. Examples of forward-looking statements include among others, statements regarding the Group's near term and longer term future capital requirements and ratios, level of ownership by the Irish Government, loan to deposit ratios, expected impairment charges, the level of the Group's assets, the Group's financial position, future income, business strategy, projected costs, margins, future payment of dividends, the implementation of changes in respect of certain of the Group's pension schemes, estimates of capital expenditures, discussions with Irish, United Kingdom, European and other regulators and plans and objectives for future operations.

 

Such forward-looking statements are inherently subject to risks and uncertainties, and hence actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to, the following: geopolitical risks, such as those associated with crises in the Middle East and increasing political tensions in respect of the Ukraine, which could potentially adversely impact the markets in which the Group operates; concerns on sovereign debt and financial uncertainties in the EU and in member countries such as Greece and the potential effects of those uncertainties on the Group; general and sector specific economic conditions in Ireland, the United Kingdom and the other markets in which the Group operates; the ability of the Group to generate additional liquidity and capital as required; the effects of extensive asset quality review and stress tests conducted by the European Central Bank any capital or other assessments undertaken by regulators; property market conditions in Ireland and the United Kingdom; the potential exposure of the Group to various types of market risks, such as interest rate risk, foreign exchange rate risk, credit risk and commodity price risk; deterioration in the credit quality of the Group's borrowers and counterparties, as well as increased difficulties in relation to the recoverability of loans and other amounts due from such borrowers and counterparties, have resulted in significant increases, and could result in further significant increases in the Group's impaired loans and impairment provisions; the impact on lending and other activity arising from emerging macro prudential policies; the performance and volatility of international capital markets; the effects of the Irish Government's stockholding in the Group (through the Ireland Strategic Investment Fund) and possible changes in the level of such stockholding; the impact of downgrades in the Group's or the Irish Government's credit ratings or outlook; the stability of the eurozone; changes in the Irish and United Kingdom banking systems; changes in applicable laws, regulations and taxes in jurisdictions in which the Group operates particularly banking regulation by the Irish and United Kingdom Governments together with the operation of the Single Supervisory Mechanism and the establishment of the Single Resolution Mechanism the exercise by regulators of powers of regulation and oversight in Ireland and the United Kingdom; the introduction of new government policies or the amendment of existing policies in Ireland or the United Kingdom; the outcome of any legal claims brought against the Group by third parties or legal or regulatory proceedings or any Irish banking inquiry more generally, that may have implications for the Group; the development and implementation of the Group's strategy, including the Group's ability to achieve net interest margin increases and cost targets; the Group's ability to address weaknesses or failures in its internal processes and procedures including information technology issues and equipment failures and other operational risks; the responsibility of the Group for contributing to compensation schemes in respect of banks and other authorised financial services firms in Ireland and the United Kingdom who may be unable to meet their obligations to customers; the inherent risk within the Group's life assurance business involving claims, as well as market conditions generally; potential further contributions to the Group sponsored pension schemes if the value of pension fund assets is not sufficient to cover potential obligations and the impact of the continuing implementation of significant regulatory developments such as Basel III, Capital Requirements Directive (CRD) IV, Solvency II and the Recovery and Resolution Directive.

 

Nothing in this document should be considered to be a forecast of future profitability or financial position and none of the information in this document is or is intended to be a profit forecast or profit estimate. Any forward-looking statement speaks only as at the date it is made. The Group does not undertake to release publicly any revision to these forward-looking statements to reflect events, circumstances or unanticipated events occurring after the date hereof. The reader should however, consult any additional disclosures that the Group has made or may make in documents filed or submitted or may file or submit to the US Securities and Exchange Commission.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEANKPELASEEF
Date   Source Headline
12th Jul 20102:39 pmRNSBlocklisting Interim Review
8th Jul 20105:00 pmRNSDirectorate Change - Appointment of a New Director
18th Jun 20103:53 pmRNSPillar 3 Disclosures 31 December 2009
16th Jun 20105:01 pmRNSNotification Of Major Interest in Shares
15th Jun 20107:00 amRNSFiling of Form 20-F
14th Jun 201010:07 amRNSTotal Voting Rights
14th Jun 20107:00 amRNSMain Securities Market Notice
11th Jun 20105:00 pmRNSMSM - Cancellation Notice
11th Jun 20103:06 pmRNSNotice of Redemption and Change of Maturity Dates
9th Jun 20106:16 pmRNSDirector/PDMR Shareholding
9th Jun 201011:28 amRNSCompletion of Rights Issue - Non US
9th Jun 20107:00 amRNSRights Issue Take Up - US
9th Jun 20107:00 amRNSRights Issue Take up - Non US
9th Jun 20107:00 amRNSDebt Equity Exchange Final Tender Results
8th Jun 201011:00 amRNSMSM - Cancellation Notice
4th Jun 20105:06 pmRNSDirector/PDMR Shareholding
26th May 20104:12 pmRNSDirector/PDMR Shareholding
25th May 20104:39 pmRNSNotification of Major Interest in Shares
24th May 20102:10 pmRNSNotification of Major Interests in Shares
21st May 20107:00 amRNSTotal Voting Rights
20th May 20108:56 amRNSDebt Equity Minimum Conversion Price - US
20th May 20108:56 amRNSDebt Equity Minimum Conversion Price - Non US
20th May 20108:56 amRNSAdmission of Stock to official lists
20th May 20107:00 amRNSDirectorate Change
20th May 20107:00 amRNSResolutions Passed at Annual General Court
20th May 20107:00 amRNSMain Securities Market Notice
19th May 20105:53 pmRNSProvisional Allotment Letter + Rights Issue Guide
19th May 20103:31 pmRNSResolutions Passed at Extraordinary General Court
17th May 20105:46 pmRNSCall Option
17th May 20108:25 amRNSUS Exchange Offer Rights Issue
17th May 20107:00 amRNSAnnouncement of Rights Issue Terms
17th May 20107:00 amRNSNON US Exchange Offers Rights Issue Terms Ann
13th May 20106:13 pmRNSAnnual Information Update
10th May 20106:13 pmRNSNotification of major interest in shares
10th May 201011:55 amRNSEarly Tender Results in Exchange Offer
10th May 201011:55 amRNSResults Announcement - Non US Offer
10th May 201011:55 amRNSCapital Raising Update
27th Apr 20103:58 pmRNSNotification of Major Interests in Shares
27th Apr 20107:00 amRNSMain Market Notice
26th Apr 20104:30 pmRNSDocuments available for Inspection - AGC
26th Apr 20104:11 pmRNSPublication of Prospectus and Circular
26th Apr 20107:00 amRNSCapital Raising Announcement - US
26th Apr 20107:00 amRNSDebt Equity Exchange - European
26th Apr 20107:00 amRNSCapital Raising Announcement - Non US
26th Apr 20107:00 amRNSDebt Equity Exchange - US
26th Apr 20107:00 amRNSInterim Management Statement
23rd Apr 20104:54 pmRNSCall Option
23rd Apr 20104:51 pmRNSMajor Interest in Shares
22nd Apr 20107:00 amRNSUpdate on Capital Assessment Review
16th Apr 20106:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.